These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1592958)

  • 21. Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores.
    Satterfield J; Swanson J; Schell A; Lee F
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):185-90. PubMed ID: 8150789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of global impressions for assessing methylphenidate effects in children with attention-deficit hyperactivity disorder.
    Mayes SD; Bixler EO
    Percept Mot Skills; 1993 Dec; 77(3 Pt 2):1215-8. PubMed ID: 8170770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of methylphenidate on problem solving in adults with ADHD.
    Tucha L; Tucha O; Sontag TA; Stasik D; Laufkötter R; Lange KW
    J Atten Disord; 2011 Feb; 15(2):161-73. PubMed ID: 20484710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teacher response to the methylphenidate (ritalin) versus placebo status of hyperactive boys in the classroom.
    Whalen CK; Henker B; Dotemoto S
    Child Dev; 1981 Sep; 52(3):1005-14. PubMed ID: 7026186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD; Carlson GA; Kelly KL; Pataki C
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):333-42. PubMed ID: 8444762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Objective assessment of covert antisocial behavior: predictive validity and ethical considerations.
    Hinshaw SP
    Ethics Behav; 2005; 15(3):259-69. PubMed ID: 16523562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
    Johnston BA; Coghill D; Matthews K; Steele JD
    J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.
    Murray LK; Kollins SH
    J Appl Behav Anal; 2000; 33(4):573-91. PubMed ID: 11214032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate in the treatment of aggression in two patients with antisocial personality disorder.
    Stringer AY; Josef NC
    Am J Psychiatry; 1983 Oct; 140(10):1365-6. PubMed ID: 6624975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.